Daridorexant (Quviviq®) for the treatment of chronic insomnia

被引：0
|
作者：
Buxeraud, Jacques [1 ]
Faure, Sebastien [2 ]
机构：
[1] 1 Rue Emile Zola, F-87100 Limoges, France
[2] Univ Angers, Fac Sante, Dept Pharm, 16 Blvd Daviers, F-49045 Angers, France
来源：
ACTUALITES PHARMACEUTIQUES | 2024年 / 63卷 / 639期
关键词：
daridorexant; dual orexin receptor antagonist; insomnia; orexin; therapeutics;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Quviviq (R) is a new drug for treating insomnia. Its active ingredient, daridorexant, is an orexin receptor antagonist, acting on both orexin-1 and 2 receptors. This first dual orexin receptor antagonist is a molecule with an innovative mechanism of action designed to inhibit arousal systems.
引用
收藏
页码：10 / 12
页数：3
相关论文
共 50 条
  • [1] Daridorexant (Quviviq) for Insomnia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1654): : 107 - 110
  • [2] Daridorexant(Quviviq)
    张云强
    许永男
    中国药物化学杂志, 2022, (12) : 978 - 978
  • [3] Daridorexant for the Treatment of Insomnia
    Robinson, Christopher L.
    Supra, Rajesh
    Downs, Evan
    Kataria, Saurabh
    Parker, Katelyn
    Kaye, Alan D.
    Viswanath, Omar
    Urits, Ivan
    HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (03):
  • [4] A randomised crossover trial of daridorexant for the treatment of chronic insomnia and nocturia
    Lederer, Katharina
    Benes, Heike
    Fine, Alan
    Shoffner, Sylvia
    Bacchelli, Sandro
    Diaz, David Castro
    Batista, Jose Emilio
    Rowles, Racheal
    Di Marco, Tobias
    Meinel, Michael
    JOURNAL OF SLEEP RESEARCH, 2025,
  • [5] DARIDOREXANT TREATMENT EFFECTIVENESS FOR CHRONIC INSOMNIA: A REAL-WORLD RETROSPECTIVE STUDY
    Fernandes, M.
    Placidi, F.
    Izzi, F.
    Castelli, A.
    Pagano, A.
    Mercuri, N. B.
    Liguori, C.
    SLEEP MEDICINE, 2024, 115 : 167 - 168
  • [6] Daridorexant for the treatment of insomnia disorder: findings and implications
    Jéssica Barreto Ribeiro dos Santos
    Michael Ruberson Ribeiro da Silva
    European Journal of Clinical Pharmacology, 2022, 78 : 1749 - 1761
  • [7] Daridorexant for the treatment of insomnia disorder: findings and implications
    Ribeiro dos Santos, Jessica Barreto
    Ribeiro da Silva, Michael Ruberson
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (11) : 1749 - 1761
  • [8] Clinical practice and actigraphic findings of daridorexant in chronic insomnia
    Hoxhaj, Domeniko
    Colitta, Alessandro
    Troilo, Leonardo
    Pascazio, Alessia
    Torresi, Francesca Buracchi
    Fabbrini, Monica
    Tassoni, Michelangelo Maestri
    Turco, Francesco
    Faraguna, Ugo
    Siciliano, Gabriele
    Bonanni, Enrica
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [9] Possible Suicidal Risk With Daridorexant, a New Treatment for Insomnia
    Nobile, Benedicte
    Olie, Emilie
    Courtet, Philippe
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (01)
  • [10] Daridorexant for insomnia disorder
    Spiegelhalder, Kai
    Feige, Bernd
    Riemann, Dieter
    Kyle, Simon D.
    LANCET NEUROLOGY, 2022, 21 (02): : 104 - 105
12345